The 1st Edition of International Conference on Cancer and Oncology Research held on November 18-19, 2024 in Dubai, UAE is successfully concluded. This year’s conference brought together an esteemed group of researchers, academicians, students, and industry professionals from all over the world to promote knowledge exchange and innovation. The two days conference highlights the key sessions, discussions, workshops, panel discussions, and outcomes from the event, focusing on actionable insights and future opportunities. The conference served as a platform for knowledge exchange, collaboration, and innovation, fostering impactful discussions and generating actionable insights.
We express our heartfelt appreciation to our session chairs and Speakers Prof. Aladar Szalay, University of Wuerzburg, Germany; Prof. Mohammad Kamil, Lotus Holistic Healthcare Institute, UAE; Prof. Ana Sabater, University of Barcelona, Spain; Dr Kostenich Viktor S, Crimean Federal University, Russia; Dr Chernorotov Vladimir A, Crimean Federal University, Russia; Dr. Sheetal Aurangabadkar,The SIA College of Health Sciences, India; Dr. Amal Almutairi, King Hussein Medical Hospital Amman, Jordan; Dr. Olesya Stativko, Oncology Center No.1 City Clinical Hospital N.a. S.S. Yudin, Russia; Dr. Anni Vuohijoki, University of Tampere, Finland; Dr. Christelle Mbangu Ngwey-Sompo, University of the Witwatersrand, South Africa; Dr. Fatimah Al-Abbad, Dammam Medical Complex\Ministry of Health\Eastern Province\KSA, Saudi Arabia; Dr. Eman M. Othman, University of Wuerzburg, Germany, Dr. Fernandi Moegni, Universitas Indonesia, Indonesia; Prof. Payman Salamati, Tehran University of Medical Sciences, Iran; Dr Roman Frolov, Eternal, UAE; Dr. Tooba Jawwad, Mahidol University, Thailand; Dr. Mostafa Eslamimahmoudabadi, Baqiyatallah University of Medical Sciences, Iran; Dr. Maryam Dorfaki, Shahrekord University of Medicine Sciences, Iran; Alisa Petkevich, Alexander Abramov and Vadim Pospelov, RUDN University, Russia; Dr. Gazalla Safdar, Cambridge University Hospital, United Kingdom; Dr. Julie Soo Fei Gan, University Hospitals of Derby and Burton NHS Foundation Trust, United Kingdom.
Once again, thank you all for your invaluable contributions, support, and participation. I look forward to the opportunity to reconvene at our next event 2nd International Conference on Cancer and Oncology Research on October 16-17, 2025 at Rome, Italy where we will continue to advance our shared goals and aspirations.